Restrictive measure for the commercialization of antimicrobials in Brazil: results achieved.
Josiane Moreira da CostaCristiano Soares de MouraCristiane Aparecida Menezes de PáduaAline Siqueira Fogal VegiSérgia Maria Starling MagalhãesMarina Barra RodriguesAndréia Queiroz RibeiroPublished in: Revista de saude publica (2019)
The results suggest that the implementation of the restrictive measure of the commercialization of antimicrobials by the National Health Surveillance Agency reduced the incidence of hospital infection by a resistant microorganism.